OpGen, Inc. (OTC:OPGN – Get Free Report) passed above its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $12.51 and traded as high as $20.00. OpGen shares last traded at $18.29, with a volume of 11,542 shares traded.
OpGen Trading Up 10.8%
The company has a market cap of $184.20 million, a P/E ratio of -3.28 and a beta of -1.77. The business’s 50 day simple moving average is $12.51 and its 200 day simple moving average is $6.04.
OpGen Company Profile
OpGen, Inc (NASDAQ: OPGN) is a precision medicine company specializing in molecular diagnostics and digital solutions for infectious disease management. Leveraging next-generation sequencing, bioinformatics and molecular assay technologies, OpGen develops tools designed to detect microbial pathogens and antimicrobial resistance markers rapidly and accurately. The company’s mission is to support clinicians and laboratories in making timely, informed treatment decisions that help curb the spread of drug-resistant infections.
Among OpGen’s key offerings is the Acuitas® AMR Gene Panel, a suite of molecular assays that identify genetic determinants of antibiotic resistance directly from positive blood cultures.
Read More
- Five stocks we like better than OpGen
- INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
- The $100 Trillion AI Story No One Is Telling You
- Buy This Stock at 9:30 AM on MONDAY!
- If You Keep Cash In A U.S. Bank Account… Read This NOW
- Trump’s AI Secret: 100X Faster Than Nvidia
Receive News & Ratings for OpGen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OpGen and related companies with MarketBeat.com's FREE daily email newsletter.
